[uam_ad id="317182"]

RIO DE JANEIRO, BRAZIL - Moderna's biotechnology science director said on Thursday he was "very pleased" with the results of his COVID-19 vaccine, which produced a promising immune response even in elderly patients, although he cautioned that "no Subscribe to our Premium Membership Plan. Already Subscribed?